Our data, our society, our health : a vision for inclusive and transparent health data science in the United Kingdom and beyond
Abstract
The last 6 years have seen sustained investment in health data science in the United Kingdom and beyond, which should result in a data science community that is inclusive of all stakeholders, working together to use data to benefit society through the improvement of public health and well‐being. However, opportunities made possible through the innovative use of data are still not being fully realised, resulting in research inefficiencies and avoidable health harms. In this paper, we identify the most important barriers to achieving higher productivity in health data science. We then draw on previous research, domain expertise, and theory to outline how to go about overcoming these barriers, applying our core values of inclusivity and transparency. We believe a step change can be achieved through meaningful stakeholder involvement at every stage of research planning, design, and execution and team‐based data science, as well as harnessing novel and secure data technologies. Applying these values to health data science will safeguard a social licence for health data research and ensure transparent and secure data usage for public benefit.
Citation
Ford , E , Boyd , A , K. F. Bowles , J , Havard , A , Aldridge , R , Curcin , V , Greiver , M , Harron , K , Katikireddi , V , Rodgers , S & Sperrin , M 2019 , ' Our data, our society, our health : a vision for inclusive and transparent health data science in the United Kingdom and beyond ' , Learning Health Systems , vol. 3 , no. 3 , e10191 . https://doi.org/10.1002/lrh2.10191
Publication
Learning Health Systems
Status
Peer reviewed
ISSN
2379-6146Type
Journal article
Rights
Copyright © 2019 The Authors. Learning Health Systems published by Wiley Periodicals, Inc. on behalf of the University of Michigan This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Description
This paper is the work of the first cohort of the Farr Institute's “Future Leaders” scheme. The Future Leaders programme was funded by the Farr Institute and was financially supported by the authors' institutions or grants.Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Related items
Showing items related by title, author, creator and subject.
-
Effect of free medicine distribution on health care costs in Canada over 3 years : a secondary analysis of the CLEAN meds randomized clinical trial
Persaud, Nav; Bedard, Michael; Boozary, Andrew; Glazier, Richard H; Gomes, Tara; Hwang, Stephen W; Jüni, Peter; Law, Michael R; Mamdani, Muhammad; Manns, Braden; Martin, Danielle; Morgan, Steven G; Oh, Paul; Pinto, Andrew D; Shah, Baiju R; Sullivan, Frank; Umali, Norman; Thorpe, Kevin E; Tu, Karen; Wu, Fangyun; Laupacis, Andreas; CLEAN Meds study team (2023-05-26) - Journal articleIMPORTANCE : Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE : To determine the effect of eliminating out-of-pocket medication ... -
Association between tobacco control policies and current smoking across different occupational groups in the EU between 2009 and 2017
So, Vivian H. T.; Best, Catherine; Currie, Dorothy; Haw, Sally (2019-08) - Journal articleBACKGROUND: This study investigated the cross-national and longitudinal associations between national tobacco control policies and current smoking in 28 European Union (EU) member states between 2009 and 2017. It also ... -
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy : study protocol of a cluster randomized clinical trial (Multi-PAP project)
Prados-Torres, Alexandra; del Cura-González, Isabel; Prados-Torres, Daniel; López-Rodríguez, Juan A.; Leiva-Fernández, Francisca; Calderón-Larrañaga, Amaia; López-Verde, Fernando; Gimeno-Feliu, Luis A.; Escortell-Mayor, Esperanza; Pico-Soler, Victoria; Sanz-Cuesta, Teresa; Bujalance-Zafra, M. Josefa; Morey-Montalvo, Mariel; Boxó-Cifuentes, José Ramón; Poblador-Plou, Beatriz; Fernández-Arquero, José Manuel; González-Rubio, Francisca; Ramiro-González, María D.; Coscollar-Santaliestra, Carlos; Martín-Fernández, Jesús; Barnestein-Fonseca, M. Pilar; Valderas-Martínez, José María; Marengoni, Alessandra; Muth, Christiane; Multi-PAP Group; Hernández-Santiago, Virginia; Azcoaga-Lorenzo, Amaya (2017-04-27) - Journal articleBackground: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of ...